A phase III study of Sulopenem for uncomplicated urinary-tract-infections(uUTI)
Phase of Trial: Phase III
Latest Information Update: 25 Jul 2017
At a glance
- Drugs Sulopenem (Primary)
- Indications Urinary tract infections
- Focus Therapeutic Use
- 25 Jul 2017 According to an Iterum Therapeutics media release, company anticipates initiation of this clinical trial in 2018.
- 11 Jan 2017 New trial record
- 05 Jan 2017 According to an Iterum Therapeutics media release, the company anticipates to commence this study under Special Protocol Assessment (SPA) with the United States Food and Drug Administration (FDA) and Scientific Advice from the European Medicines Agency (EMA) by the end of 2017.